We report a case of severe community-acquired pneumonia caused by Streptococcus pyogenes (Lancefield Group A streptoccocus) that was complicated by a streptococcal toxic shock syndrome. Although this micro-organism is an uncommon cause of community-acquired pneumonia, previously well individuals may be infected and the clinical course may be fulminant. A household contact was the likely point of infection. Invasive group A streptococcal disease continues to remain an important cause of morbidity and mortality in the community and therefore will continue to be encountered by intensive care physicians. Treatment of Group A streptococcal infection remains penicillin; however, clindamycin should be added in severe infection.
Streptococcus pyogenes (S. pyogenes) is an ubiquitous micro-organism properly classified as a Lancefield Group A β-haemolytic streptococcus. Its common associations include acute pharyngitis, impetigo (pyoderma) and the non-suppurative sequelae, acute rheumatic fever and acute glomerulonephritis. In addition it is responsible for serious invasive illness, e.g., necrotizing fasciitis and the streptococcal toxic shock syndrome (TSS). Since 1985 there has been an apparent increase in the number of invasive group A β-haemolytic streptococcus infections reported worldwide. Despite this, these organisms remain a rare cause of sporadic severe community-acquired pneumonia 1, 2 . We report a case of severe community-acquired pneumonia in a healthy male caused by Streptococcus pyogenes. TSS complicated the course of illness.
CASE REPORT
A 33-year-old previously well man presented with a one-week history of cough productive of purulent sputum accompanied by high fever, left-sided pleuritic chest pain and anorexia. He denied having a sore throat. He did not smoke and denied recent overseas travel. On admission he was pyrexial (40.3°C), with a pulse rate of 130 beats per minute and a blood pressure of 110 /55 mmHg. His respiratory rate was 32 per minute. On auscultation decreased air entry was noted in the left lower zone of his chest accompanied by bronchial breathing. He had a Glasgow Coma Score (GCS) of 15. A chest radiograph showed left lower lobe consolidation consistent with pneumonia. Initial laboratory results revealed a white blood cell count of 3.7x10 9 /l with toxic changes, platelet count of 38x10 9 /l, urea 15 mmol/l, creatinine 101 µmol/l and an INR of 1.8. An arterial blood gas (ABG) taken on 8 litres of oxygen per minute via Hudson mask showed a P a O 2 of 137 mmHg, P a CO 2 of 35 mmHg and a bicarbonate of 20 mmol/l. A diagnosis of community-acquired lobar pneumonia was made. He was initially admitted to a medical ward where he received intravenous fluids, a beta lactam antibiotic and oxygen therapy. Six hours after admission he deteriorated with hypotension unresponsive to fluid therapy and was transferred to the intensive care unit for management. On admission to ICU his BP was 80/50 mmHg and pulse 130 beats per minute. Respiratory rate was 20 per minute and laboured. Repeat ABG (on facemask CPAP 7.5 cm water, F i O 2 0.7) showed a pH 7.33, P a O 2 62 mmHg, P a CO 2 32 mmHg and bicarbonate 17.6 mmol/l. Other laboratory results included a Na + 131 mmol/l, urea 17 mmol/l, creatinine 291 mmol/l, platelets 40x10 9 /l, INR 2.0 and peripheral white cell count 4.7x10 9 septic shock was made. He was treated empirically with the broad-spectrum antimicrobials cefotaxime and erythromycin. He subsequently required endotracheal intubation and mechanical ventilation for respiratory failure and inotropic support with dopamine was needed to restore perfusion pressure. Over the next 24 hours oliguria, hyperkalaemia and a worsening metabolic acidosis developed. Continuous veno-venous haemodiafiltration (CVVHDF) was therefore commenced and was tolerated well. Disseminated intravascular coagulation (DIC) manifest by thombocytopaenia, raised INR and low fibrinogen required supportive blood product transfusion. After 48 hours in ICU his pneumonia had progressed to involve both lung fields and a large leftsided pleural effusion developed which required thoracostomy tube drainage. S. pyogenes was grown from a sample of the pleural fluid. In addition S. pyogenes was cultured from blood and sputum. This was subsequently serotyped as M 1. No exotoxin studies were performed. The organism was highly sensitive to benzyl penicillin which was subsequently continued as monotherapy. After four days of supportive therapy his circulation and gas exchange had improved to the extent that dopamine could be discontinued and he could be weaned from mechanical ventilation. He subsequently received 50% oxygen via a Hudson mask with satisfactory gas exchange. After a total of eight days in ICU he was transferred to the renal ward where he required a further seven days of haemodialysis for anuric renal failure. He was discharged home two weeks later with improving of renal function. To investigate the source of his infection, throat swabs were performed on his wife, his three school-age daughters and his mother-in-law. One of his daughters was positive for S. pyogenes of the same serotype and she was treated with oral penicillin. It was postulated that this was the source of his infection.
DISCUSSION
Over the last 15 years there has been a dramatic change in the epidemiology of invasive Lancefield Group A β-haemolytic streptococcal infections with worldwide increases being reported 1 . Concurrently, reports of a severe systemic illness associated with Group A β-haemolytic streptococcal infection that resembled the staphylococcal toxic shock syndrome began to appear 3 and in 1993 the group A streptococcal TTS was formally defined 4 .
Group A β-haemolytic streptococcus causes a wide array of infections which may be classified as invasive if the organism has been isolated from a previously sterile site, e.g., pleural space, or non-invasive if isolated from a non sterile site e.g., pharynx. Two well studied non-suppurative sequelae, acute rheumatic fever and acute glomerulonephritis, also occur. Commonly encountered non-invasive infections include acute pharyngitis ("strep throat") and impetigo (pyoderma). Invasive infection with this organism carries an appreciable mortality in some series up to 60% 1, 5 . Most notable examples are necrotizing fasciitis , streptococcal myositis and the streptococcal TSS.
In the pre-antibiotic era, Group A β-haemolytic streptococcus accounted for many cases of bronchopneumonia and up until the late 1970s were implicated in outbreaks in closed populations; e.g., military recruits. Cases of sporadic streptococcal community acquired pneumonia due to this organism have been infrequently reported 6, 7 and today this organism accounts for less than 1% of all cases with the commonest identified pathogens being Streptococcus pneumonia, Legionella pnuemoniae, gram negative bacteria, and Staphyloccocus aureus 2 . During the mid to late 1980s as the incidence of invasive Group A β-haemolytic streptococcus illness began to increase around the world, lower respiratory tract involvement was reported as part of this spectrum 1,8,9 . In two of these studies the commonest manifestations however remained soft tissue infections. Pneumonia was less common, accounting for less than 15% of all reported infections 8, 9 . Group A β-haemolytic streptococcal pneumonia typically presents as a bronchopneumonia but pure lobar involvement as evidenced by our case can occur. The clinical signs and symptoms do not allow differentiation from other pneumonic pathology; however high fever and marked pleuritic chest pain are common. The most characteristic feature however is the rapid accumulation of a pleural effusion, noted in up to 80% of cases compared to 10% pneumonia from other causes 7 . This is usually thin and serosanguinous in nature, though loculation with abscess formation can occur.
The occurrence of shock and multiorgan failure early in the course of infection characterizes the streptoccocal TSS. The syndrome is defined as isolation of the streptococcus from either sterile or nonsterile sites accompanied by clinical signs of severity which must include hypotension (SBP <90mmHg) and two or more of renal impairment, coagulopathy, liver involvement, ARDS or skin rash 4 . Unlike the staphylococcal toxic shock syndrome, most patients with streptococcal TSS are bacteraemic. TSS can accompany invasive lower respiratory tract involve-ment. One study reported its occurrence in just over 25% of those with pneumonia with a 33% mortality 8 . Our patient satisfied criteria for TSS. Although hypotension developed subsequent to admission, organ failure (coagulopathy) was present on admission. In some cases of streptococcal TSS, organ failure may precede hypotension and remains quite compatible with the diagnosis 4 .
The chief virulence factor in the Group A β-haemolytic streptococcal cell wall appears to be the M protein, which effectively diminishes complement activation and thereby decreases phagocytosis. Strains rich in this protein are therefore highly resistant to phagocytosis and multiply rapidly in blood. Those that lack M protein are essentially avirulent 10 . The predominant serotypes of this organism have changed with time. In the U.S.A. and in the U.K., new M serotypes became prevalent in late 1980s; namely M 1, 3 and 18 in the U.S.A. and M 1 and 28 in the U.K. 11 . Although strains of a number M types have been isolated from those with invasive disease, there has been a definite and consistent tendency for serotypes 1 and 3 to be associated with life-threatening infections. Susceptibility to these strains may in part be related to fluctuations in population immunity. The Group A streptococcal exotoxins belong to a group of substances called superantigens. These agents require no antigen processing by antigen-presenting cells before being able to stimulate the T cell. Hence superantigens can directly activate thousands of times more T cells than would normally be the case. Streptococcal pyrogenic exotoxin A appears to be the most virulent, it is responsible for pyrexia, changes to the blood brain barrier, the scarlet fever rash and other organ damage (especially the heart). Transmission of Group A β-haemolytic streptococcal infection within households has been well documented 8 . The presence of the same serotype in a family member was the probable although not conclusive source of our patient's infection.
Pleural fluid analysis remains the most useful diagnostic test in identifying the stage of a parapneumonic effusion and guiding therapy. If the effusion is frankly purulent, confirming the diagnosis of an empyema, it should be drained without delay 12 . If not, the specimen should be analysed 13 . A positive gram stain implies advanced stage of disease and also suggests immediate drainage 14 . A recent meta-analysis suggests that pH measurement should be undertaken in other effusions and where the pH is <7.0, a chest tube should be inserted 12 . The reason for the low pH is the local metabolic activity of inflammatory cells and bacteria. In situations where a streptococcal infection is established, drainage will decrease the quantity of toxin that is released 10 . If the effusion is of moderate size it may be an important contributor to arterial hypoxaemia in the presence of respiratory failure. Large effusions may compromise haemodynamic function by reducing venous return to the heart 14 . In a seriously ill patient requiring mechanical ventilation, drainage may be also beneficial for these reasons.
Penicillin remains the treatment of choice for both invasive and non-invasive infection 15 . Uncomplicated Group A β-haemolytic streptococcal pneumonia carries a low mortality with penicillin therapy and appropriate supportive care. Severe invasive infections, where a large number of bacteria are found, may reduce the efficacy of penicillin. This probably only occurs in overwhelming sepsis, necrotizing fasciitis or myositis. In such cases the large inoculum size will slow bacterial growth rendering the drug less effective. Eagle described this effect in 1952 16. Clindamycin should be considered in this situation. Clindamycin is thought to be effective largely because it acts by inhibition of protein synthesis 5 . This decreases the production of M proteins and halts toxin production. It is rapidly bactericidal and is unaffected by inoculum size. A current approach therefore is to combine penicillin and clindamycin 17 . Our patient was commenced on benzylpenicillin on returning positive cultures for Group A β-haemolytic streptococcal and after 48 hours his septicaemia improved clinically, resulting in continuation of monotherapy. Relapse has been described if treatment is discontinued prematurely and even with appropriate therapy fever may persist for up to seven days in 60% of patients 6, 18 .
In invasive disease, millions of clones of T cells are activated along with streptococcal superantigens, cytokines, complement and clotting cascades. These factors lead to the clinical picture of shock and multiorgan failure. The fact that intravenous immunoglobulin G can reverse hyperproliferation of T cells, neutralize superantigens and down-regulate cytokine production has lead to its use 17 . None of the reports on this practice has been conclusive. However, ordinary human globulin contains considerable amounts of toxin-neutralizing antibodies, and if given at an early stage of invasive disease, may have a beneficial effect 12 . Clindamycin has been shown to increase opsonization of bacteria 17 . This may be relevant in light of successful use of pooled immunoglobulins in patients with invasive Group A β-haemolytic streptococcal infection.
